To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system to treat pain. The company's strategic focus on peripheral rather than central acting therapeutics is an attempt to avoid the known side-effects of existing central acting agents. The primary molecular targets addressed by PainCeptor are members of the ASIC ion channel family and nerve growth factor (NGF) and NGF receptors. Though PainCeptor refers to itself as a biopharmaceutical company on its website, its two primary publicly reported drug discovery projects aim to deliver small molecule therapeutics.
Additional recommended knowledge
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "PainCeptor_Pharma". A list of authors is available in Wikipedia.|